Gulf Pharmaceutical Industries P.S.C. Stock Forecast for 2023 - 2025 - 2030

Updated on 04/24/2024

Stock Rating
-6
Price Target
0.72
Consensus
Underperform
Downside
-24.21%
Analysts
0
Stock Rating
-6
Downside
-24.21%
Analysts
0
Price Target
0.72

Gulf Pharmaceutical Industries P.S.C. Stock Forecast and Price Target

Based on the current earnings figures, this year's price targets for Gulf Pharmaceutical Industries P.S.C. were recently set by distinguished experts, with an average mark of 0.72. If it reached this goal, it would represent a potential downside of approximately -24.21% from the previous closing price in April, 2024. The high end is 0.72, and the low is 0.72.

0.72

-24.21% Downside

Sell
Sell

Gulf Pharmaceutical Industries P.S.C. Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, Gulf Pharmaceutical Industries P.S.C.'s Price has grown by 100.00%, from 0.00 to 0.00. For the next year, analysts are expecting Fair Value to reach 1.01 – an increase of 100.00%. Over the next seven years, experts predict that Fair Value will grow by 100.00%.

2024 Fair Value Forecast
1.01
2025 Fair Value Forecast
1.11
2026 Fair Value Forecast
1.21
2027 Fair Value Forecast
1.32
2028 Fair Value Forecast
1.45
2029 Fair Value Forecast
1.58
2030 Fair Value Forecast
1.73

Gulf Pharmaceutical Industries P.S.C. Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Gulf Pharmaceutical Industries P.S.C.'s Revenue has grown by 181.85%, from 581.20M to 1.64B. For the next year, 0 analysts project Gulf Pharmaceutical Industries P.S.C.'s Revenue to drop by 26.59%, reaching 1.20B. By 2030, professionals believe that Gulf Pharmaceutical Industries P.S.C.'s Revenue will decrease by 18.13%, reaching 1.34B – a concerning trend for the company.

2024 Rev Forecast
1.20B
2025 Rev Forecast
1.23B
2026 Rev Forecast
1.36B
2027 Rev Forecast
1.47B
2028 Rev Forecast
1.38B
2029 Rev Forecast
1.33B
2030 Rev Forecast
1.34B

Gulf Pharmaceutical Industries P.S.C. Dividend per Share Forecast for 2023 - 2025 - 2030

Gulf Pharmaceutical Industries P.S.C. Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
-15400000.00

Gulf Pharmaceutical Industries P.S.C. EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Gulf Pharmaceutical Industries P.S.C.'s EBITDA has grown by 144.25%, rising from -153.90M to 68.10M. According to 1 major analysts, Gulf Pharmaceutical Industries P.S.C.'s EBITDA will fall by 15.71% in the next year, reaching 57.40M. Over the next seven years, experts predict that Gulf Pharmaceutical Industries P.S.C.'s EBITDA will grow at a rate of 7.69%.

2024 EBITDA Forecast
0.06B
2025 EBITDA Forecast
0.08B
2026 EBITDA Forecast
0.08B
2027 EBITDA Forecast
0.07B
2028 EBITDA Forecast
0.07B
2029 EBITDA Forecast
0.07B
2030 EBITDA Forecast
0.07B

Gulf Pharmaceutical Industries P.S.C. EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Gulf Pharmaceutical Industries P.S.C.'s EBIT has gone down from -252.20M to -30.70M – a 87.83% drop. In the next year, analysts believe that EBIT will reach -89.70M – an increase of 192.18%. For the next seven years, the forecast is for EBIT to grow by 227.39%.

2024 EBIT Forecast
-89700000.00
2025 EBIT Forecast
-141274510.00
2026 EBIT Forecast
-89888261.56
2027 EBIT Forecast
-76372063.30
2028 EBIT Forecast
-86137504.46
2029 EBIT Forecast
-104378556.65
2030 EBIT Forecast
-100509591.49

Gulf Pharmaceutical Industries P.S.C. EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, Gulf Pharmaceutical Industries P.S.C.'s EPS has grown by 100.00%, from -0.02 to 0.00. For the next year, analysts are expecting EPS to reach -0.03 – an increase of 100.00%. Over the next seven years, experts predict that EPS will grow by 100.00%.

2024 EPS Forecast
-0.03
2025 EPS Forecast
0.02
2026 EPS Forecast
0.00
2027 EPS Forecast
0.01
2028 EPS Forecast
0.01
2029 EPS Forecast
0.02
2030 EPS Forecast
0.01